Markets › United States › NYSE › EBS

Emergent BioSolutions Inc

NYSE:EBSHealthcareCBOEFTSE:MRUTNASDAQ:NQUSSG

——At close · Market cap — · Next earnings Wed 28 Oct

Emergent BioSolutions Inc · Forecasts · TradingHolo

As of Mon 19 Oct

2 buy0 hold1 sell

Buy consensus · 3 analysts

Average · last_month$10.00

Analysts1

Average · last_quarter$10.00

Average · last_year$11.00

Average · all_time$31.25

EPS actual vs estimate, last 8 reports

Analyst consensus · USD

Fiscal period	Revenue	EPS	Net income	Analysts
Thu, 31 Dec 2026	$733.05M$729.35M – $736.75M	$0.3250$0.3229 – $0.3271	$18.43M	1

Actual vs consensus

Report	EPS est.	Actual	Surprise	Revenue est.	Revenue
Wed, 5 Aug 2026	−$0.0850	−$3.49	−4008.5%	$177.5M	$234.3M
Thu, 30 Apr 2026	−$0.2500	$0.2100	+184.0%	$145M	$156.1M
Thu, 26 Feb 2026	$0.1100	−$0.4300	−490.9%	$217.5M	$148.7M
Wed, 29 Oct 2025	−$0.1200	$1.06	+983.3%	$217.5M	$231.1M
Wed, 6 Aug 2025	−$0.2600	$0.1600	+161.5%	$203.67M	$140.9M
Wed, 7 May 2025	$0.4900	$0.7100	+44.9%	$219M	$222.2M
Mon, 3 Mar 2025	−$0.3500	$0.0500	+114.3%	$279M	$189.3M
Wed, 6 Nov 2024	$0.4900	$1.37	+179.6%	$259M	$293.8M